- If my cancer recurred, I might die before they were old enough to remember me, but if I had radiation, I might mortgage everyone’s future quality of life.
- Skipping radiation would increase chances that my cancer recurred, but radiation would increase my risk for secondary cancers considerably; my short-term survival rate might be better with radiation, but my long-term prognosis was possibly better without it.
- A few short months ago, a drug called olaparib became the first PARP inhibitor approved for treatment of ovarian or breast cancer.
Read the full article, click here.
@NYTmag: “”Individualized medicine is lonely.” Readers share their stories from the new frontier of cancer treatments.”
Readers share their stories.
How New Cancer Treatments Are Shaping Lives